Your Confidential Body Composition & Fat Oxidation Report
You qualify for CoreAge Rx™ physician-monitored Tirzepatide. Unlike standard caloric deprivation that burns off athletic skeletal muscle, Tirzepatide's dual GIP + GLP-1 agonism directly enhances lipid oxidation in visceral and subcutaneous fat depots while preserving muscle tone. Here is your protocol comparison:
How Your Incretin Options Compare:
| Clinical Standard | Big Pharma Retail | Commercial Telehealth | CoreAge Rx™ Direct |
|---|---|---|---|
| Starting Dose Cost | $1,350/mo | $199 – $299/mo | $129.00/mo (FLAT) |
| Max 15mg Maintenance Dose | $1,350/mo (Same) | $499 – $650/mo (Hiked) | $129.00/mo (FLAT) |
| Monthly Platform / Membership Fees | $0.00 | $99.00 / month | $0.00 (Zero Fees) |
| Doctor Consultation & Prescription | $150 – $250 clinic copay | $49 – $99 initial copay | $0.00 (Included Free) |
| Compounding Pharmacy Standard | N/A (Branded Pen) | Third-Party Compounding | Licensed US 503A Cleanroom |
| Titration Escalation Penalty | Zero (Already Max Price) | 250% – 350% Price Hike | Zero (Never Price-Hiked) |
| Direct Messaging with Clinical Team | Limited to clinic hours | Varies / Delayed | Included • 7 Days/Week |
CoreAge Rx™ Flat-Rate Compounded Tirzepatide Protocol
State-Licensed US 503A Sterile Compounding • Zero Insurance Paperwork • $0 Doctor Evaluation
All-Inclusive Telehealth Care Standards
$0 Board-Certified Physician Evaluation
Licensed US medical doctor evaluates your health history and determines appropriate incretin dosage.
State-Licensed 503A Sterile Compounding
Compounded strictly in verified US cleanrooms adhering to USP <797> sterile preparation standards.
Temperature-Controlled Cold Express Shipping
Shipped in insulated cold packaging direct to your door with all injection supplies and instructions.
Locked Flat-Rate Pricing Guarantee
Your monthly price is permanently locked. No price increases when your doctor increases your dosage.
Compounded Prescription Disclosure: Compounded medications are prepared by state-licensed 503A compounding pharmacies pursuant to a valid patient-specific prescription issued by an independent US board-certified physician. Compounded drugs are not FDA-approved and are prescribed under state medical practice guidelines.
Medical Assessment Notice: This clinical diagnostic is an educational tool and does not constitute formal medical diagnosis. Prescription eligibility is determined solely by an independent US licensed physician during medical intake.
Affiliate Transparency: Deals Direct Daily may receive affiliate compensation from telehealth partners for completed patient intakes at zero extra cost to you.